The Signal
GhostThe Signal is a weekly-style briefing on how AI is moving into healthcare, pharma and enterprise decision-making, with each issue pairing a news item with what it means for pharma, medical affairs and market access teams. Readers get concise context on regulation, clinical trials and governance developments, framed around practical implications.